WHO Model Prescribing Information: Drugs Used in Anaesthesia
(1989; 60 pages) [French] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoPreface
Ver el documentoIntroduction
Cerrar esta carpetaPremedication
Ver el documentoAtropine
Ver el documentoChloral hydrate
Ver el documentoDiazepam
Ver el documentoPromethazine
Abrir esta carpeta y ver su contenidoGeneral anaesthetics and oxygen
Abrir esta carpeta y ver su contenidoLocal anaesthetics
Abrir esta carpeta y ver su contenidoNon-opioid analgesics
Abrir esta carpeta y ver su contenidoOpioid analgesics and antagonists
Abrir esta carpeta y ver su contenidoMuscle relaxants and cholinesterase inhibitors
Abrir esta carpeta y ver su contenidoBlood substitutes
Abrir esta carpeta y ver su contenidoSolutions for correcting water and electrolyte imbalance
Abrir esta carpeta y ver su contenidoAntacid for use in obstetric practice
Ver el documentoAnaesthesia at the District Hospital
Ver el documentoSelected WHO publications of related interest
Ver el documentoBack cover


Group: sedative
Tablet: 2 mg, 5 mg
Injection: 5 mg/ml in 2-ml ampoule

General information

Diazepam is a benzodiazepine with anxiolytic properties, a centrally mediated muscle-relaxant effect and, when used intravenously, an anticonvulsant action. It is metabolized in the liver to several active metabolites, which are mainly excreted in the urine as glucuronides.

The response, which persists for 12-24 hours, becomes evident 30-90 minutes after oral administration and 1-5 minutes after intravenous injection. The plasma half-life is 20-50 hours.

Clinical information


In general surgery:

• premedication before major or minor surgery

• to relieve anxiety and provide light sedation for endoscopic procedures and surgery under local anaesthesia

• in combination with pethidine, when other anaesthetic agents are not available, for emergency reduction of fractures.

Dosage and administration


Adults and children over 12 years: 5-10 mg orally 2 hours before surgery.

Anxiety relief and light sedation

Adults and children over 12 years: 200 micrograms/kg i.v. immediately before medical or surgical intervention.

In order to ensure stability, diazepam for injection should not be mixed with other drugs in syringes or infusion fluids, nor should it be diluted before use except in saline or glucose solution. Unused diazepam solutions should be discarded within 6 hours.

It should be administered directly into the cubital vein at a rate of no more than 1 ml/min to reduce the risk of thrombophlebitis. Preparations of diazepam in an oil-in-water emulsion are available which reduce the risk of thrombophlebitis after injection.

Accidental intra-arterial injection can cause severe local necrosis.


• Age less than 12 years.
• Known hypersensitivity to benzodiazepines.
• Parenteral administration is contraindicated in shocked or comatose patients.


Equipment for resuscitation should be immediately available.

Diazepam should be administered with particular caution to patients with myasthenia gravis. Patients with chronic obstructive airway disease are at particular risk of respiratory depression.

Diazepam should be used with great caution, in much reduced doses, and only when essential in elderly and debilitated patients, and in patients with chronic pulmonary insufficiency or chronic renal or hepatic disease.

Ambulatory patients should be warned that diazepam may impair their ability to drive or operate machinery for up to 24 hours.

Use in pregnancy

Use in pregnancy should be avoided whenever possible. An increased incidence of malformations has been reported in some studies among infants born to mothers who have received diazepam during the first trimester of pregnancy, although other, large-scale prospective studies have failed to confirm this.

Use of diazepam during labour can result in marked fetal sedation and hypotonia.

Adverse effects

Paradoxical reactions including irritability, excitability, hallucinations, increased muscle spasticity and sleep disturbances have been reported, particularly in elderly patients and in children.

Rare but serious adverse reactions include leukopenia, jaundice and hypersensitivity reactions.

Drug interactions

The effects of phenothiazines, barbiturates, monoamine oxidase inhibitors and other antidepressants may be potentiated.


Signs include somnolence, ataxia, dysarthria, diminished reflexes, confusion and coma. Paradoxical excitement may occur in children. Unless the specific benzodiazepine antagonist flumazenil is available, treatment should be symptomatic and directed to the management of respiratory depression and shock.


Diazepam should be stored in tightly closed containers protected from light.

Ir a la sección anterior
Ir a la siguiente sección
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 29 octubre 2018